A Delaware judge has allowed more
than 70,000 lawsuits over discontinued heartburn drug Zantac to
go forward, ruling that expert witnesses can testify in court
that the drug may cause cancer. .
A Delaware judge has permitted more than 70,000 lawsuits regarding the discontinued heartburn medication Zantac to move forward. Expert witnesses will testify that the drug may cause cancer, a claim disputed by the drug's former makers, GSK, Pfizer, Sanofi, and Boehringer Ingelheim. The companies are planning to appeal.
This summary covers recent health news highlights, including Gilead's Trodelvy failing in a bladder cancer trial, Pfizer's optimistic sales forecast for Lorbrena, U.S. lawmakers' concerns about GenScript's China links, FDA's cautious stance on MDMA for PTSD, and the EU's recommendation for Valneva's chikungunya vaccine.
A Delaware judge has allowed over 70,000 lawsuits against Zantac to proceed, citing expert witnesses claiming the drug may cause cancer. The drugmakers GSK, Pfizer, Sanofi, and Boehringer Ingelheim are set to appeal. In 2020, the FDA ordered Zantac's removal from the market due to cancer risk concerns.
Delaware Judge Lets More Than 70,000 Zantac Lawsuits Go Forward usnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from usnews.com Daily Mail and Mail on Sunday newspapers.